{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:46Z","timestamp":1790777986449,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["F32DK116495"],"award-info":[{"award-number":["F32DK116495"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R21ES029258"],"award-info":[{"award-number":["R21ES029258"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM135258"],"award-info":[{"award-number":["R01GM135258"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["T32ES007148"],"award-info":[{"award-number":["T32ES007148"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006812","name":"Center for Integrated Healthcare, U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002741"],"award-info":[{"award-number":["BX002741"]}],"id":[{"id":"10.13039\/100006812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The effects of exposure to Myclobutanil, a triazole fungicide, on the development and progression of nonalcoholic fatty liver disease (NAFLD) are unclear, but activation of nuclear receptors (NRs) is a known mechanism of azole-induced liver toxicity. Farnesoid X receptor (FXR) is a NR and is highly expressed in the liver and intestine. Activation of FXR tightly regulates bile acid (BA), lipid and glucose homeostasis, and inflammation partly through the induction of fibroblast growth factor 15 (FGF15; human ortholog FGF19). FXR activation is downregulated during NAFLD and agonists are currently being explored as potential therapeutic strategy. In this study, we aimed to clarify the effects of Myclobutanil exposure on FXR activation and NAFLD development. Reporter assay showed Myclobutanil treatment, following FXR activation with potent FXR agonist (GW4064), resulted in a dose-dependent decrease of FXR activity. Furthermore, a 10-day study in male mice demonstrated that cotreatment with Myclobutanil led to an 80% reduction of GW4064-induced ileal expression of Fgf15. In a diet-induced NAFLD study, low-fat diet (LFD) fed mice administered myclobutanil displayed decreased FXR activity in the liver and ileum, while high-fat-high-sugar-diet (HFHSD) fed mice showed an increase in hepatic FXR activity and an induction of target genes regulated by constitutive androstane receptor and\/or pregnane X receptor. Our work demonstrates Myclobutanil inhibits FXR activity and modulates FXR activity differentially in mice fed LFD or HFHSD. Our studies suggest the importance of understanding how Myclobutanil could contribute to BA dysregulation in disease states such as NAFLD.<\/jats:p>\n               <jats:p\/>","DOI":"10.1093\/toxsci\/kfac129","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T22:27:35Z","timestamp":1670884055000},"page":"387-399","source":"Crossref","is-referenced-by-count":10,"title":["Myclobutanil-mediated alteration of liver-gut FXR signaling in mice"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-3653","authenticated-orcid":false,"given":"Rulaiha","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University , New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University , New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University , Piscataway, NJ 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-8115","authenticated-orcid":false,"given":"Zakiyah","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University , New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Brinker","sequence":"additional","affiliation":[{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Buckley","sequence":"additional","affiliation":[{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University , New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University , Piscataway, NJ 08854, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University , New Brunswick, NJ 08901, USA"},{"name":"VA New Jersey Health Care System, Veterans Administration Medical Center , East Orange, NJ 07017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"2024071000132331300_kfac129-B1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40495-017-0085-2","article-title":"Role of FXR in liver inflammation during nonalcoholic steatohepatitis","volume":"3","author":"Armstrong","year":"2017","journal-title":"Curr. Pharmacol. Rep"},{"key":"2024071000132331300_kfac129-B2","doi-asserted-by":"crossref","first-page":"e64721","DOI":"10.1371\/journal.pone.0064721","article-title":"Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH","volume":"8","author":"Bjursell","year":"2013","journal-title":"PLoS One"},{"key":"2024071000132331300_kfac129-B3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jnutbio.2006.12.006","article-title":"Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition","volume":"18","author":"Cave","year":"2007","journal-title":"J. Nutr. Biochem"},{"key":"2024071000132331300_kfac129-B4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.bbagrm.2016.04.010","article-title":"RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome","volume":"1859","author":"Cui","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"2024071000132331300_kfac129-B5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/00032719.2017.1338713","article-title":"Determination of pesticides in the respirable fraction of airborne particulate matter by high-performance liquid chromatography-tandem mass spectrometry","volume":"51","author":"Di Filippo","year":"2018","journal-title":"Anal. Lett"},{"key":"2024071000132331300_kfac129-B6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1369-5274(98)80087-8","article-title":"Antifungals: Mechanism of action and resistance, established and novel drugs","volume":"1","author":"Georgopapadakou","year":"1998","journal-title":"Curr. Opin. Microbiol"},{"key":"2024071000132331300_kfac129-B7","author":"Goldman","year":"1986"},{"key":"2024071000132331300_kfac129-B29","author":"G\u00fcnther","year":"2018"},{"key":"2024071000132331300_kfac129-B8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3892\/etm.2011.328","article-title":"Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease","volume":"2","author":"Higuchi","year":"2011","journal-title":"Exp. Ther. Med"},{"key":"2024071000132331300_kfac129-B9","author":"Joint FAO\/WHO Meeting on Pesticide Residues (JMPR), Standards & Scientific Advice on Food Nutrition","year":"2015"},{"key":"2024071000132331300_kfac129-B10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"2024071000132331300_kfac129-B11","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3390\/foods10102242","article-title":"Tebuconazole fungicide induces lipid accumulation and oxidative stress in HepG2 cells","volume":"10","author":"Kwon","year":"2021","journal-title":"Foods"},{"key":"2024071000132331300_kfac129-B12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1039\/c8tx00008e","article-title":"Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators","volume":"7","author":"Lake","year":"2018","journal-title":"Toxicol. Res. (Camb.)"},{"key":"2024071000132331300_kfac129-B15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/10807039.2015.1133242","article-title":"An international database for pesticide risk assessments and management","volume":"22","author":"Lewis","year":"2016","journal-title":"Hum. Ecol. Risk Asses"},{"key":"2024071000132331300_kfac129-B13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/me.2010-0014","article-title":"Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner","volume":"24","author":"Li","year":"2010","journal-title":"Mol. Endocrinol"},{"key":"2024071000132331300_kfac129-B14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/toxsci\/kfm065","article-title":"Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity","volume":"97","author":"Martin","year":"2007","journal-title":"Toxicol. Sci"},{"key":"2024071000132331300_kfac129-B16","first-page":"603","article-title":"Impact of cholesterol metabolism and the LXR\u03b1-SREBP-1c pathway on nonalcoholic fatty liver disease","volume":"23","author":"Nakamuta","year":"2009","journal-title":"Int. J. Mol. Med"},{"key":"2024071000132331300_kfac129-B17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","article-title":"The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease","volume":"51","author":"Okushin","year":"2016","journal-title":"J. Gastroenterol"},{"key":"2024071000132331300_kfac129-B18","doi-asserted-by":"crossref","first-page":"e002","DOI":"10.1621\/nrs.13002","article-title":"Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium","volume":"13","author":"Oshida","year":"2015","journal-title":"Nucl. Recept. Signal"},{"key":"2024071000132331300_kfac129-B19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: Natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science (New York, NY)"},{"key":"2024071000132331300_kfac129-B20","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/jaoac\/88.5.1491","article-title":"Determination of 22 triazole compounds including parent fungicides and metabolites in apples, peaches, flour, and water by liquid chromatography\/tandem mass spectrometry","volume":"88","author":"Schermerhorn","year":"2005","journal-title":"J. AOAC Int"},{"key":"2024071000132331300_kfac129-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2017.06.023","article-title":"The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis","volume":"330","author":"Schumacher","year":"2017","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"2024071000132331300_kfac129-B22","doi-asserted-by":"crossref","first-page":"38128","DOI":"10.1074\/jbc.M111.256677","article-title":"Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid \u03b2-oxidation","volume":"286","author":"Sheng","year":"2011","journal-title":"J. Biol. Chem"},{"key":"2024071000132331300_kfac129-B23","first-page":"re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein Roy","year":"2009","journal-title":"Sci. Signal"},{"key":"2024071000132331300_kfac129-B24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc"},{"key":"2024071000132331300_kfac129-B25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2016.09.013","article-title":"Myclobutanil worsens nonalcoholic fatty liver disease: An in vitro study of toxicity and apoptosis on HepG2 cells","volume":"262","author":"Stellavato","year":"2016","journal-title":"Toxicol. Lett"},{"key":"2024071000132331300_kfac129-B26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/chir.22353","article-title":"Acute toxicity, bioactivity, and enantioselective behavior with tissue distribution in rabbits of Myclobutanil enantiomers","volume":"26","author":"Sun","year":"2014","journal-title":"Chirality"},{"key":"2024071000132331300_kfac129-B27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/mol.116.106617","article-title":"Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal Fxr signaling pathway","volume":"91","author":"Sun","year":"2017","journal-title":"Mol. Pharmacol"},{"key":"2024071000132331300_kfac129-B28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23450","article-title":"Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine","volume":"51","author":"Thomas","year":"2010","journal-title":"Hepatology"},{"key":"2024071000132331300_kfac129-B30","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"2024071000132331300_kfac129-B31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest"},{"key":"2024071000132331300_kfac129-B32","doi-asserted-by":"crossref","first-page":"e43961","DOI":"10.1371\/journal.pone.0043961","article-title":"Tissue specific induction of p62\/Sqstm1 by farnesoid X receptor","volume":"7","author":"Williams","year":"2012","journal-title":"PLoS One"},{"key":"2024071000132331300_kfac129-B33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/chir.22265","article-title":"Stereoselective degradation of chiral fungicide myclobutanil in rat liver microsomes","volume":"26","author":"Yan","year":"2014","journal-title":"Chirality"},{"key":"2024071000132331300_kfac129-B34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"2024071000132331300_kfac129-B35","doi-asserted-by":"crossref","first-page":"e105930","DOI":"10.1371\/journal.pone.0105930","article-title":"Genome-wide binding and transcriptome analysis of human farnesoid X receptor in primary human hepatocytes","volume":"9","author":"Zhan","year":"2014","journal-title":"PLoS One"},{"key":"2024071000132331300_kfac129-B36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2008.12.117","article-title":"Suppression of interleukin-6-induced C-reactive protein expression by Fxr agonists","volume":"379","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2024071000132331300_kfac129-B37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist way-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfac129\/48438722\/kfac129.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/191\/2\/387\/49199016\/kfac129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/191\/2\/387\/49199016\/kfac129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:13:42Z","timestamp":1720570422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/191\/2\/387\/6895109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12,13]]},"published-print":{"date-parts":[[2023,2,17]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfac129","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,12,13]]}}}